Article Figures & Data
Figures
- Figure 1
- Frequency of medications used among participants.
Tables
Variables n (%) Age, mean±SD 61.36±10.82 <40 2 (0.3) 40-49 95 (12.7) 50-59 245 (32.7) 60-69 238 (31.7) 70-79 126 (16.8) ≥80 44 (5.9) PSA, mean±SD 1.88±3.88 HgA1c, mean±SD 6.58±2.60 FBG, mean±SD 6.90±2.63 BMI Underweight 11 (1.5) Normal weight 127 (17.6) Overweight 300 (41.6) Obese 283 (39.3) Smoking Yes 111 (15.8) No 584 (83.0) Prostate biopsy Yes 15 (2.0) No 734 (98.0) Diabetes Yes 349 (46.7) No 398 (53.3) Dyslipidemia Yes 390 (52.6) No 351 (47.4) Chronic kidney disease Yes 40 (5.4) No 701 (94.6) Hypertension Yes 331 (44.5) No 412 (55.5) Values are presented as numbers and presentages (%). SD: standard deviation, PSA: prostate-specific antigen, HgA1c: hemoglobin A1c, FBG: fasting blood glucose, BMI: body mass index
Variables Mean±SD P-values Age <40 1.03±0.60 0.001 40-49 1.05±1.04 50-59 1.31±1.27 60-69 1.94±1.92 70-79 2.99±8.29 ≥80 3.41±4.67 BMI Underweight 9.74±27.23 0.001 Normal weight 2.07±2.47 Overweight 1.70±2.11 Obese 1.68±1.84 Smoking Yes 1.79±2.76 0.742 No 1.93±4.21 Prostate biopsy Yes 4.07±2.71 0.027 No 1.83±3.89 Diabetes Yes 1.73±1.94 0.327 No 2.01±5.01 Dyslipidemia Yes 1.77±2.01 0.739 No 2.01±5.26 Chronic kidney disease Yes 3.20±4.66 0.07 No 1.81±3.85 Hypertension Yes 1.99±2.42 0.49 No 1.79±4.77 Values are presented as mean ± standard deviation (SD).
BMI: body mass index
- Table 3
- Correlation between prostate-specific antigen level, hemoglobin A1c, and fasting blood glucose.
Protein Correlation HbA1c FBG PSA r 0.04 0.04 p 0.30 0.34 PSA: prostate-specific antigen, HgA1c: hemoglobin A1c, FBG: fasting blood glucose
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.